MedImmune Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

MedImmune Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 1, 2016	G1 Therapeutics	$47.0M Series C	Bihua Chen	Catalio Capital, Hatteras Venture Partners, RA Capital, Ryan Allis, AJU IB Investment, Cowen Private Investments, Eshelman Ventures, Franklin Templeton, Lumira Ventures, Mountain Group Partners, RA Capital Management, Rock Springs Capital, Tavistock Group
Feb 1, 2015	G1 Therapeutics	$33.0M Series B	Fred Eshelman, Peter Kolchinsky	Catalio Capital, Hatteras Venture Partners, RA Capital, Ryan Allis, Boxer Capital, Lumira Ventures, Mountain Group Partners
Nov 1, 2013	Astria Therapeutics	$32.0M Series B	Jean George	Advanced Technology Ventures, OrbiMed, Polaris Partners, Venrock, Clarus Ventures, SV Health Investors
Oct 1, 2013	G1 Therapeutics	$13.0M Series A	Michael Gutch	Catalio Capital, Hatteras Venture Partners, Ryan Allis, Mountain Group Partners
Dec 12, 2012	Cerapedics	$19.0M Series C	CVF, Sam Wu	NGN Capital, OrbiMed
Nov 6, 2012	Ambit Pharmaceuticals	$25.0M Other Equity	David Bonita	Aisling Capital, Apposite Capital, Forward Ventures, Gimv, GrowthWorks, Radius Ventures, Roche Ventures
Nov 1, 2012	AGTC	$38.0M Series B	SR One, Ed Hurwitz	MPM Capital, Robert Garland, OrbiMed, Osage University Partners, Tectonic Ventures, James Barrett, Intersouth Partners, InterWest Partners
Jul 1, 2012	Coferon	$12.0M Series B	Hatteras Venture Partners, Ascent Biomedical Ventures, Michael Gutch	Digitalis Ventures
Dec 1, 2011	Astria Therapeutics	$8.0M Series A	—	Advanced Technology Ventures, OrbiMed, Polaris Partners, Venrock, Clarus Ventures, Michael Ross
Jun 10, 2011	Ambit Pharmaceuticals	$30.0M Series D	Allan Marchington	Forward Ventures, Genechem, Gimv, GrowthWorks, Horizon Technology Finance, NovaQuest Capital Management, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Apr 1, 2010	Astria Therapeutics	$39.0M Series A	Clarus Ventures, MedImmune Ventures, SV Health Investors	Advanced Technology Ventures, OrbiMed, Polaris Partners, Venrock
Jan 1, 2010	VentiRx Pharmaceuticals	$25.0M Series A	Maggie Flanagan LeFlore	Aisling Capital, Alta Partners, ARCH Venture Partners, Domain Associates, Frazier Healthcare Partners
Nov 1, 2007	Ambit Biosciences	$49.0M Series D	—	OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Genechem, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, NovaQuest Capital Management, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche
Oct 1, 2006	VaxInnate	$40.0M Series C	New Leaf Venture Partners	Pitango Venture Capital, Canaan Partners, CHL Medical Partners, HealthCare Ventures, Oxford Bioscience Partners